Literature DB >> 4113115

Early appearance of serum -fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3'-methyl-4-dimethylaminoazobenzene.

R Kroes, G M Williams, J H Weisburger.   

Abstract

Entities:  

Keywords:  Age Factors; Alpha Fetoproteins--analysis; Animals, Laboratory; Biology; Blood Proteins; Cancer; Clinical Research; Correlation Studies; Demographic Factors; Diseases; Examinations And Diagnoses; Hemic System; Hepatic Effects; Histology; Jaundice; Laboratory Examinations And Diagnoses; Laboratory Procedures; Neoplasms; Physiology; Population; Population Characteristics; Research Methodology; Signs And Symptoms; Statistical Studies; Studies

Mesh：

Substances：

Year:  1972        PMID： 4113115

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  [Carcinofetal antigens. I. alpha-fetoprotein (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-02-15

Review 2.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

Review 3.  Hepatoma--nature's model tumor. A review.

Authors:  F F Becker
Journal:  Am J Pathol       Date:  1974-01       Impact factor: 4.307

4.  Alpha-feto-protein during development and in disease.

Authors:  A Adinolfi; M Adinolfi
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

5.  Purification of mouse alpha1-fetoprotein and preparation of specific peroxidase conjugates for its cellular localization.

Authors:  W D Kuhlmann
Journal:  Histochemistry       Date:  1975-07-30

6.  Excretion of alpha-foetoprotein in the urine of rats during exposure to 3'-methyl-4-dimethylaminoazobenzene.

Authors:  J H Boss; G Zajicek; E Okon; E Rosenmann
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.